The spread of COVID-19 is one the biggest public health challenges we have faced, and research has a key role to play in the fight against it. Research is helping us to develop diagnostic tests, treatments and vaccines and to prevent and manage the spread of the virus.
To ensure COVID-19 research started quickly as possible, the Health Research Authority and the devolved administrations developed a fast-track process to review new studies for certain types COVID-19 research studies, such as vaccine studies, and amendments to existing studies, often within a few days of application.
Due to the high volume of research studies underway and significant progress with the roll-out of the vaccine programme, the fast track process is now only open to new studies in COVID-19 that meet a limited set of criteria. Details on which studies can apply for fast track is given in our guidance on applying for fast track.
How to apply for fast-track approval
Our fast-track approval process provides dedicated support to researchers to enable their study to be swiftly reviewed by a Research Ethics Committee and approvals specialists.
To request fast-track approval, please contact firstname.lastname@example.org. Please do not directly contact a Research Ethics Committee
The process is managed via the Director of the Approvals Service, and research leads in the devolved administrations if appropriate. More detail about the process can be found in our guidance about applying for fast track review.
How to amend an existing study
To understand how and when to amend an existing study because of the impact of the virus, read our guidance for sponsors, sites and researchers.
We have summarised how existing requirements for providing information to research participants and recording consent apply in COVID-19 research. For more information, read our guidance on seeking consent in COVID-19 research.
Using patient data
Ordinarily, applications are made for support from the Confidentiality Advisory Group (CAG) where confidential patient information is to be processed without consent for research and non-research activities. A temporary arrangement has been made for COVID-19 studies going through the fast-track review process, in which support from CAG is not required. However, CAG is providing advice as part of the fast-track process, as all such studies must still apply for research ethics committee review. For more information about this process, read our guidance for using patient data.
See all approved studies
It is vital that the research community and wider public is able to see information about ongoing research and its findings.
We also have a fast-track transparency process, in which information about each approved COVID-19 study is published on our website within days of approval. See the approved research studies section for more information.
How we are working during the pandemic
Applications for all other types of research are being accepted for review. The only exception is applications for review of undergraduate and master’s level research, which are suspended until September 2021